In addition, treatment with pIL-12 GET can induce a potent proliferation of memory (CD44+) CD4+ and CD8+ T cells, but not NK cells in the peripheral blood (Figure 5 and Figure 6) leading to induction of protection from tumor relapse and metastasis. The gene discussed is CD8A; the disease is neoplasm.